• Amitriptyline HCl (B2231): Technical Guidance for Neuropharm

  2026-04-30

  Amitriptyline HCl (SKU B2231) is designed for precise neurotransmitter receptor modulation in neuropharmacology, mood disorder, and neurodegenerative disease research. This small molecule compound is best suited for workflows requiring high receptor selectivity, rapid solution preparation, and strict storage conditions to maintain purity. It should not be used where long-term solution stability or off-target mechanistic data are required.

• Erastin: A Selective Ferroptosis Inducer for Cancer Biology

  2026-04-30

  Erastin is a validated ferroptosis inducer that selectively triggers iron-dependent, non-apoptotic cell death in RAS- or BRAF-mutant tumor cells. As a research tool, it enables precise dissection of oxidative stress pathways and resistance mechanisms in cancer biology. Recent evidence supports its role in overcoming multidrug resistance in ovarian cancer models.

• Live-Dead Cell Staining Kit: Validating Regenerative Assays

  2026-04-29

  Explore how the Live-Dead Cell Staining Kit enables precise Calcein-AM Propidium Iodide staining for advanced cell viability assays. This article uniquely bridges regenerative biomaterials research and robust assay design for enhanced experimental reproducibility.

• Urolithin A: Precision Modulation of Mitochondrial Dynamics

  2026-04-29

  Explore how Urolithin A, a gut microbiota-derived metabolite, enables precision modulation of mitochondrial quality control and biogenesis. This article uniquely analyzes Urolithin A's mechanistic synergy with cellular metabolic pathways, offering advanced assay guidance and bridging recent breakthroughs in liver fibrosis research.

• ATF4-H2S Axis Mitigates Doxorubicin-Induced Cardiotoxicity

  2026-04-28

  This study reveals that activating transcription factor 4 (ATF4) protects against doxorubicin-induced cardiomyopathy by upregulating CSE-mediated hydrogen sulfide (H2S) production, which counters oxidative stress. The findings provide mechanistic insight into molecular defenses against anthracycline cardiotoxicity and highlight ATF4 as a potential therapeutic target.

• TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm

  2026-04-28

  This study identifies TMEM16F-mediated lipid scrambling as a critical suppressor of ferroptosis at the plasma membrane, showing that its inhibition both sensitizes tumor cells to ferroptotic death and enhances tumor immune rejection. These findings reveal mechanistic details of phospholipid dynamics in ferroptosis execution and suggest new therapeutic strategies integrating ferroptosis inducers and immune checkpoint blockade.

• Ziprasidone Hydrochloride: Bioavailability Breakthroughs & G

  2026-04-27

  Explore how Ziprasidone Hydrochloride advances antitumor and neuroscience research through GOT1 inhibition and enhanced bioavailability. This article reveals critical formulation innovations, actionable protocol guidance, and scientific insights beyond standard assay protocols.

• PP 3 as a Precision Negative Control in Src Kinase Signaling

  2026-04-27

  Explore how 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3), a research use only chemical, defines new standards for specificity in Src kinase signaling pathway research. This article delivers advanced assay guidance and unique mechanistic insights not found elsewhere.

• GSTA1 Drives Glutathione Loss in α-Amanitin Liver Injury

  2026-04-26

  This study uncovers a paradoxical role of GSTA1 in α-amanitin-induced hepatotoxicity, showing that upregulation of GSTA1 exacerbates glutathione depletion and oxidative stress in liver tissue. The findings highlight GSTA1 as a potential therapeutic target and biomarker for acute toxic liver injury.

• Amikacin Sulfate: Mechanistic Insights for Mycobacterial Res

  2026-04-25

  Amikacin Sulfate is a potent aminoglycoside antibiotic with dose-dependent bactericidal activity against Mycobacterium avium and Staphylococcus aureus. Its efficacy is driven by targeted ribosomal inhibition and efficient intracellular uptake, with documented safety parameters in preclinical models. APExBIO provides validated research-grade Amikacin Sulfate for rigorous translational workflows.

• Amitriptyline HCl: Technical Guidance for Neuropharmacology

  2026-04-24

  Amitriptyline HCl (SKU B2231) is a tricyclic compound optimized for investigating neurotransmitter receptor modulation in neuropharmacology and mood disorder research. It is best suited for in vitro and in vivo studies requiring precise inhibition of serotonin and norepinephrine receptors. This compound is not intended for long-term solution storage or unvalidated mechanistic exploration outside of its documented receptor targets.

• BMP4-GPX4 Modulation Improves RGC Survival in Glaucoma Model

  2026-04-24

  This study demonstrates that BMP4-GPX4 signaling alleviates ferroptosis in retinal ganglion cells (RGCs) and enhances their differentiation after retinal stem cell transplantation in a mouse model of glaucoma with elevated intraocular pressure. These findings support the therapeutic potential of targeting BMP4-GPX4 in neurodegenerative eye disease.

• Sulfaphenazole Restores Tissue Perfusion in Pressure Injurie

  2026-04-23

  This study demonstrates that sulfaphenazole, a CYP 2C6/2C9 inhibitor and sulfonamide antibiotic, significantly reduces the severity of thermal and pressure injuries in an aging mouse model by rapidly restoring tissue perfusion and decreasing inflammation. These findings provide valuable mechanistic insights into ischemia–reperfusion injury and suggest new avenues for antibacterial and wound healing research.

• Lanabecestat (AZD3293): Precision BACE1 Inhibition for Synap

  2026-04-23

  This article provides a mechanistic and strategic deep-dive into Lanabecestat (AZD3293) as a next-generation BACE1 inhibitor for Alzheimer’s disease research. Integrating fresh evidence on synaptic safety at moderate amyloid-beta reduction, it outlines practical guidance for translational teams, differentiates from conventional product summaries, and positions APExBIO’s offering as a critical tool for forward-thinking workflows.

• PERK Loss Sensitizes Colorectal Cancer to Ferroptosis via SL

  2026-04-22

  This study uncovers how loss of PERK function enhances ferroptosis in colorectal cancer by downregulating SLC7A11, a key transporter in redox homeostasis. The findings reveal a mechanistic link between ER stress responses and ferroptosis sensitivity, with implications for overcoming therapy resistance in tumor biology.

16472 records 1/1099 page Next 12345 下5页 Last page